Abstract
Tumor-associated protein survivin is a bifunctional protein that can participate either in the regulation of cell division or in the inhibition of apoptosis depending on its location in the cell and its structural state. The aim of the present work was to obtain monospecific antibodies to survivin targeting various sites in the protein and suitable for the study of its structural and functional features. The ability of the antibodies to detect survivin in tumor cells and mammary tumor tissues has been assessed. Antibodies targeting the (1–22) and (95–105) fragments of the protein have been shown to have the highest specific activity. Antibodies targeting the (1–22) site preferentially bound to survivin-containing complex (presumably a dimer of survivin) in immunoblotting, whereas antibodies targeting the (95–105) site detected only the monomeric form of the protein. Analysis of malignant mammary tumor samples showed that monomeric survivin was present only in tumor tissue samples, whereas survivin-containing complex was expressed both in tumor tissues and in the tissues adjacent to the tumor. Antibodies targeting the (1–22) site were shown to preferentially detect survivin localized in the cell nuclei (and involved in the regulation of mitosis) in immunocytochemistry, while those targeting the (95–105) site stained the nucleoplasm and cytoplasm at all stages of the cell cycle. Therefore, the antibodies obtained can serve as a useful tool for structural and functional research on survivin.
Similar content being viewed by others
Abbreviations
- AB:
-
antibodies
- ELISA:
-
enzyme-linked immunosorbent assay
- IFA:
-
incomplete Freund’s adjuvant
- CFA:
-
Freund’s complete adjuvant
- BIR:
-
highly conserved domain characteristic of all members of the apoptosis inhibitor protein family
- CPC:
-
chromosomal passenger complex
- DAB:
-
3,3′-diaminobenzidine
- DAPI:
-
4′,6-diamidino-2-phenylindole dihydrochloride
- EDT:
-
1,2-ethanedithiol
- FITC:
-
fluorescein isothiocyanate
- Fmoc:
-
9-fluorenylmethoxycarbonyl
- KLH:
-
keyhole limpet hemocyanin
- OVA:
-
ovalbumin
- PBS:
-
phosphate buffered saline
- pH 7.4:
-
containing 2.7 mM KCl
- 140 mM NaCl:
-
8.1 mM Na2HPO4, and 1.5 mM KH2PO4
- RecSurv:
-
recombinant survivin
- TBS-T:
-
a buffer containing 20 mM Tris-HCl, 137 mM NaCl, and 0.1% Tween 20, pH 7.6
References
Zhang, S.Q., Qiang, S.Y., Yang, W.B., Jiang, J.T., and Ji, Z.Z., Ai Zheng, 2004, vol. 35, pp. 40–47.
Wang, W., Luo, H., and Wang, A., J. Surg. Oncol., 2006, vol. 93, pp. 578–584.
Tarcowski, R., Kotarski, J., Polak, G., and Wojcierowski, J., Ginecol. Pol., vol. 72, pp. 1539–1542.
Ferrandina, G., Legge, F., Martinelli, E., Ranelletti, F.O., Zannoni, G.F., Lauriola, L., Gessi, M., Gallotta, V., and Scambia, G., Br. J. Cancer, 2005, vol. 92, pp. 271–277.
Moon, W.S. and Tarnawski, A.S., Hum. Pathol., 2003, vol. 34, pp. 1119–1126.
Mahotka, C., Liebmann, J., Wenzel, M., Suschek, C.V., Schmitt, M., Gabbert, H.E., and Gerharz, C.D., Cell Death Differ., 2002, vol. 9, pp. 1334–1342.
Colnaghi, R., Connell, C.M., Barret, R.M.A., and Wheatley, S.P., J. Biol. Chem., 2006, vol. 281, pp. 33450–33456.
Dohi, T., Beltrami, E., Wall, N.R., Plescia, J., and Altieri, D.C., J. Clin. Invest., 2004, vol. 114, pp. 1117–1127.
Kennedy, S.M., O’Driscoll, L., Purcell, R., Fitz-Simons, N., McDermott, E.W., Hill, A.D., O’Higgins, N.J., Parkinson, M., Linehan, R., and Clynes, M., Br. J. Cancer, 2003, vol. 88, pp. 1077–1083.
Vischioni, B., van der Valk, P., Span, S.W., Kruyt, F.A., Rodriguez, J.A., and Giaccone, G., Ann. Oncol., 2004, vol. 15, pp. 1654–1660.
Sohn, D.M., Kim, S.Y., Baek, M.J., Lim, C.W., Lee, M.H., Cho, M.S., and Kim, T.Y., Biochem. Pharmacol., 2006, vol. 60, pp. 289–292.
Kleinberg, L., Florenes, V.A., Nesland, J.M., and Davidson, B., Am. J. Clin. Pathol., 2007, vol. 128, pp. 389–397.
Adida, C., Haioun, C., Gaulard, P., Lepage, E., Morel, P., Briere, J., Dombret, H., Reyes, F., Diebold, J., Gisselbrecht, C., Salles, G., Altieri, D.C., and Molina, T.J., Blood, 2000, vol. 96, pp. 1921–1925.
Fangusaro, J.R., Jiang, Y., Holloway, M.P., Caldas, H., Singh, V., Boué, D.R., Hayes, J., and Altura, R.A., Br. J. Cancer, 2005, vol. 92, pp. 359–365.
Knauer, S.K., Bier, C., Schlag, P., Fritzmann, J., Dietmaier, W., Röbel, F., Klein-Hitpass, L., Kovács, A.F., Döring, C., Hansmann, M.L., Hofmann, W.K., Kunkel, M., Brochhausen, C., Engels, K., Lippert, B.M., Mann, W., and Stauber, R.H., Cell Cycle, 2007, vol. 6.I.12, pp. 1502–1509
Engelsma, D., Rodrigues, J.A., Fish, A., Giaccone, G., and Fornerod, M., Traffic, vol. 8, pp. 1496–1502.
Knauer, S.K., Krämer, O.H., Knösel, T., Engels, K., Röbel, F., Koväcs, A.F., Dietmaier, W., Klein-Hitpass, L., Habtemichael, N., Schweitzer, A., Brieger, J., Röbel, C., Mann, W., Petersen, I., Heinzel, T., and Stauber, R.H., FASEB J., 2007, vol. 21, pp. 207–216
Muchmore, S.W., Chen, J., Jakob, C., Zakula, D., Matayoshi, E.D., Wu, W., Zhang, H., Li, F., Ng, S.C., and Altieri, D.C., Mol. Cell, 2000, vol. 6, pp. 173–182.
Jeyaprakash, A.A., Klein, U.R., Lindner, D., Ebert, J., Nigg, E.A., and Conti, E., Cell, 2007, vol. 131, pp. 271–285.
Pavlyukov, M.S., Antipova, N.V., Balashova, M.V., Vinogradova, T.V., Kopantzev, E.P., and Shakhparonov, M.I., J. Biol. Chem., 2011, vol. 286, pp. 23296–23307.
Altieri, D.C., Nat. Rev. Cancer, 2008, vol. 8, pp. 61–70.
Vol’pina, O.M., Titova, M.A., Zhmak, M.N., Koroev, D.O., Oboznaya, M.B., Volkova, T.D., and Ivanov, V.T., Russ. J. Bioorg. Chem., 2002, vol. 28, pp. 349–356.
Chantalat, L., Skoufias, D.A., Kleman, J.-P., Jung, B., Dideberg, O., and Margolis, R.L., Mol. Cell, 2000, vol. 6, pp. 183–189.
Song, Z., Yao, X., and Wu, M., J. Biol. Chem., 2003, vol. 278, pp. 23130–23140.
Sun, C., Nettesheim, D., Liu, Z., and Olejniczak, E.T., Biochemistry, 2005, vol. 44, pp. 11–17.
Akhidova, E.V., Volkova, T.D., Koroev, D.O., Kim, Ia.S., Filatova, M.P., Vladimirova, N.M., Karmakova, T.A., Zavalishina, L.E., Andreeva, Iu.Iu., and Vol’pina, O.M., Russ. J. Bioorg. Chem., 2010, vol. 36, pp. 178–186.
Pfaff, E., Mussgay, M., Bohm, H.O., Schulz, G.E., and Schaller, H., EMBO J., 1982, vol. 1, pp. 869–874.
Conway, E.M., Zwerts, F., Van Eygen, V.V., DeVriese, A., Nagai, N., Luo, W., and Collen, D., Am. J. Pat., 2003, vol. 163, pp. 935–946.
Singh, S.K., Moretta, D., Almaguel, F., Wall, N.R., De Leon, M., and De Leon, D., Growth Factors, 2007, vol. 25, pp. 363–372.
Colnaghi, R. and Wheatley, S.P., J. Biol. Chem., 2010, vol. 285, pp. 22592–22604.
Caldas, H., Jiang, Y., Holloway, M.P., Fangusaro, J., Mahotka, C., Conway, E.M., and Altura, R.A., Oncogen, 2005, vol. 24, pp. 1994–2007.
Fortugno, P., Wall, N.R., Giodini, A., O’Connor, D.S., Plescia, J., Padgett, K.M., Tognin, S., Marchisio, P.C., and Altieri, D.C., J. Cell Sci., 2002, vol. 115, pp. 575–585.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.V. Akhidova, T.D. Volkova, D.O. Koroev, I.Yu. Yakupov, M.V. Kalintseva, L.E. Zavalishina, A.P. Kaplun, O.O. Zharskaya, O.V. Zatsepina, O.M. Volpina, 2013, published in Bioorganicheskaya Khimiya, 2013, Vol. 39, No. 3, pp. 326–337.
Rights and permissions
About this article
Cite this article
Akhidova, E.V., Volkova, T.D., Koroev, D.O. et al. Production of affinity purified antipeptide antibodies to survivin for structural and functional studies of the protein. Russ J Bioorg Chem 39, 288–298 (2013). https://doi.org/10.1134/S1068162013030023
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162013030023